Clinical trials would be impossible to carry out successfully without the collaborative effort of multiple entities working towards the same goal. Having so many different people involved means a wide range of stakeholders all working together.
Let’s take a look at the key stakeholders in a clinical trial and their contributions to it.
Patients, the primary stakeholders, are perhaps the most important part of any clinical trial. Without them, the trial would be impossible since they are the ones who provide the results that researchers need to make evaluations about their point of study. The patients involved are often those who need treatment for ailments, so the success of a trial can be very important to them.
Some trials also have patient advocates to make sure that the rights of patients are not being violated.
The other major stakeholders in any clinical trial are the researchers themselves. They are responsible for designing the study, conducting it, and analyzing its results. Because the trial results will affect them professionally, they have a vested interest in the quality of the study and how accurate it is.
Most researchers don’t have the funds to carry out long-term trials with expensive equipment like clinical data capture systems and drugs. Thus, most clinical trials are sponsored by entities with the capital to make it happen. These are often pharmaceutical companies who would want to patent the drugs found to be effective or academic institutions.
Since their money is going into making the trial happen, sponsors are financially interested in the trial outcome.
Regulatory agencies are also major stakeholders in such trials because any new treatments and drugs first have to go through them before they are introduced in public health. As an example, the FDA has a lengthy process to approve drugs before they enter the market, so these agencies are invested in the outcome and execution of such trials to make sure there are no issues.
In medicine, since the use of drugs and treatments can easily become a matter of life and death, these agencies need to keep a close eye on the trials and make sure everything is going smoothly.
Healthcare providers are also personally interested in clinical trials, as the ones who have to deliver new treatments or drugs to patients.
It is important for them that these trials are successful and carried out without problems since any problems with the drug or treatment will first be directed towards them as the ones who administered it in the first place. As such, they are also stakeholders in the outcome of the trials.
Clinical PURSUIT Makes it Easier to Manage Data in Clinical Trials
Most clinical trials are complex and need all data and information to be collected properly. Without this, making an accurate analysis becomes difficult, and in some cases, outcomes can also be skewed.